Forus announces $150 million Series C at $3 billion valuation

Forus announced a $150 million Series C at a $3 billion valuation, four months after announcing a $1 billion valuation.

The company says it now supports millions of people across all 50 U.S. states, is used by doctors treating patients in 85% of U.S. residential ZIP codes, and works with nine of the 15 largest global biopharma companies.